Advancements in medical research are vital to helping medical professionals save lives and improve the health of the population. Also, medical research can lead to profits for those who are in the position to capitalize from it. This may have been the reason behind Merck deciding to invest $600 million into a new company , which focuses on biotechnology and was started at the University of Michigan.
The bio-life science field is an exciting and innovative industry to be a part of. New business enterprises are attracted to the field because of the demand for new discoveries, many of which could be used in medical treatment. This provides excellent opportunity to make a good profit. One bio-life science company has chosen Michigan as the site for its new start-up lab, which will specialize in genetic research. The lab plans to focus on processing genetic testing for age-related macular degeneration.